May 16, 2016 11:27 am
Researchers from Cold Spring Harbor Laboratory have discovered a new growth-regulating pathway in plants that has eluded scientists for years. In addition, by tweaking this new pathway the scientists have found a way to gently upregulate stem cell growth, boosting maize’s yield by up to 50 percent, which could have important real-world applications.
May 9, 2016 9:52 am
While many industries are blazing new trails in pursuit of new technologies, pharma appears to be lagging behind, often adopting a watch and wait approach. In most industries, the pace of technology change has increased so much that corporate IT leaders who don't embrace emerging trends end up behind the competition and eventually out of business. Can we really say the same is true for pharma companies?
May 2, 2016 9:05 am
Surface Plasmon Resonance (SPR) and phage display are both techniques that are well suited to high-throughput environments. In particular, phage display has found utility in antibody production. SPR has been explored as a means of substantially reducing the time and number of steps required for phage antibody isolation, while simultaneously providing kinetics and affinity information that are the hallmarks of the SPR technique.
April 4, 2016 9:48 am
Data is at the crux of today’s biological research and the potential of big data in scientific research is huge. To ensure successful and productive research and development, pharmaceutical and life science companies must invest more in solutions that support the early preclinical phases of the drug discovery process to help researchers better understand the biology of diseases.
March 31, 2016 9:30 am
The human brain needs a large amount of energy to function properly, and researchers at the University of Illinois have reported in a new study that the health of brain metabolism in young adults may predict fluid intelligence – the capacity to solve unusual logic-based problems in novel situations.
March 30, 2016 10:10 am
Bioscience Technology spoke with Neurophysiologist Stephen Morairty, Ph.D., of SRI International, about his work on neurodegenerative diseases, such as Huntington’s.